Defining and analyzing geoepidemiology and human autoimmunity
- PMID: 20034761
- DOI: 10.1016/j.jaut.2009.11.018
Defining and analyzing geoepidemiology and human autoimmunity
Abstract
Autoimmune diseases cumulatively affect 5-10% of the industrial world population and are a significant cause of morbidity and mortality. In recent decades rates are rising worldwide, and autoimmunity can no longer be associated solely with the more developed "Western" countries. Geoepidemiology of autoimmune diseases portrays the burden of these illnesses across various regions and ethnic populations. Furthermore, Geoepidemiology may yield important clues to the genetic and triggering environmental mechanisms of autoimmunity. In this review we compiled and discuss in depth abundant geoepidemiological data pertaining to four major autoimmune conditions, namely type-1 diabetes mellitus, multiple sclerosis, autoimmune thyroid disease, and inflammatory bowel disease. The following key results manifested in this review: 1) Ethno-geographic gradients in autoimmune disease risk are attributable to a complex interplay of genetic and environmental pressures. 2) Industrial regions, particularly Northern Europe and North America, still exhibit the highest rates for most autoimmune diseases. 3) Methods particularly useful in demonstrating the significant influence of genetic and environmental factors include comparative ethnic differences studies, migration studies, and recognition of 'hotspots'. 4) Key environmental determinants of geographical differences include diminished ultraviolet radiation exposure, Western or affluence-related lifestyle, infection exposure, environmental pollutants, nutritional factors and disease-specific precipitants (e.g., iodine exposure).
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Geoepidemiology, gender and autoimmune disease.Autoimmun Rev. 2012 May;11(6-7):A386-92. doi: 10.1016/j.autrev.2011.11.012. Epub 2011 Nov 28. Autoimmun Rev. 2012. PMID: 22142547 Review.
-
Geoepidemiology of autoimmune rheumatic diseases.Nat Rev Rheumatol. 2010 Aug;6(8):468-76. doi: 10.1038/nrrheum.2010.86. Epub 2010 Jun 22. Nat Rev Rheumatol. 2010. PMID: 20567251 Review.
-
Geo-epidemiology and autoimmunity.J Autoimmun. 2010 May;34(3):J163-7. doi: 10.1016/j.jaut.2009.12.005. Epub 2009 Dec 28. J Autoimmun. 2010. PMID: 20056534
-
Infection, vaccines and other environmental triggers of autoimmunity.Autoimmunity. 2005 May;38(3):235-45. doi: 10.1080/08916930500050277. Autoimmunity. 2005. PMID: 16126512
-
Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?Springer Semin Immunopathol. 2002 Dec;24(3):297-321. doi: 10.1007/s00281-002-0110-2. Springer Semin Immunopathol. 2002. PMID: 12503056 Review.
Cited by
-
A cutting edge overview: psoriatic disease.Clin Rev Allergy Immunol. 2013 Apr;44(2):109-13. doi: 10.1007/s12016-012-8309-z. Clin Rev Allergy Immunol. 2013. PMID: 22359072 Review.
-
N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.FEBS J. 2015 Jun;282(12):2247-59. doi: 10.1111/febs.13294. Epub 2015 Apr 23. FEBS J. 2015. PMID: 25864722 Free PMC article.
-
Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies.BMC Med. 2013 Jul 25;11:171. doi: 10.1186/1741-7015-11-171. BMC Med. 2013. PMID: 23885887 Free PMC article.
-
Risk factors for immune-related adverse events: what have we learned and what lies ahead?Biomark Res. 2021 Nov 3;9(1):79. doi: 10.1186/s40364-021-00314-8. Biomark Res. 2021. PMID: 34732257 Free PMC article. Review.
-
Sex-specific and regional differences in the prevalence of diagnosed autoimmune diseases in Germany, 2022.Res Health Serv Reg. 2025 Mar 26;4(1):3. doi: 10.1007/s43999-025-00061-5. Res Health Serv Reg. 2025. PMID: 40133715 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical